Navigation Links
GlaxoSmithKline Consumer Healthcare to Reach 85 Percent of the World's Smokers with Quit Aids
Date:3/9/2009

file of therapeutic nicotine products when used as directed(4). Therapeutic nicotine is recommended as a first-line treatment for smoking addiction in United States, United Kingdom and World Health Organization (WHO) guidelines(2,3,5). To date, GSK's therapeutic nicotine has helped more than six million people around the world quit smoking, and as a result, has greatly reduced their exposure to the risks of cancer and other smoking-related diseases(6).

These products are designed specifically to break the addiction cycle by offering a gradual, controlled delivery of nicotine to the body, helping to relieve withdrawal symptoms.

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, NicoDerm(R) CQ and Commit(R), NiQuitin and Nicabate, as well as many medicine cabinet staples such as Aquafresh(R), Panadol(R), Crocin(R), Horlicks(R) and Sensodyne(R). GlaxoSmithKline Consumer Healthcare continues to develop innovative products to help all smokers find their best support system and achieve their goal of being cigarette free.

About GlaxoSmithKline

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and consumer healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

(1) Jha, et al; A Nationally Representative Case - Control Study of Smoking and Death in India; NEJM, 2008

(2) World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008. Geneva: World Health Organization; 2008 [cited 2008 Mar 21]. Available from: http://www.who.int/tobacco/mpower/en/

(3) Fiore MC, Jaen CR, Baker TB, e
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline Consumer Healthcare Helps to Bridge Oral Care Gap in Appalachia
2. Activplant Corporation Announces Global Agreement with GlaxoSmithKline
3. GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
4. GlaxoSmithKlines Drug Will Become New Clinical Gold Standard by 2012 for the Treatment of Relapsed/Refractory CLL
5. GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding
6. GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases –
7. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
8. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
9. GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
10. AUDIO from Medialink and GlaxoSmithKline: Give Kids A Boost For Their Health!
11. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... This Latest Guidebook for Conducting Pharma Clinical Trials ... only provided a comprehensive and thorough knowledge of the ... registration but also introduced the practical operation how to ... use the Chinese trial venues to keep drug development ... step. , The audiences of this guidebook are overseas ...
(Date:7/29/2014)... controversy over how best to treat patients after they,ve ... until the cancer comes back or provide men with ... a new study from Thomas Jefferson University ... patients make a more informed decision. , "We are ... author Robert Den, M.D., Assistant Professor of Radiation Oncology ...
(Date:7/29/2014)... principle suitable to find out which preferences patients have ... health economic evaluations, some (primarily methodological) issues still need ... pilot project by the German Institute for Quality and ... Process (AHP), CA is the second method tested by ... outcome-specific results to an overall value , In ...
(Date:7/29/2014)... repeatedly shown that death rates rise in association with ... in the summer of 2003, for example, resulted in ... by Dr. Alex-andra Schneider at the Institute of Epidemiology ... of extreme temperatures on the number of deaths caused ... both high and low temperatures in the study. , ...
(Date:7/29/2014)... stressful situations better than others, and it,s not ... differences in how they respond. , Researchers have ... of genetically identical mice that predicts how well ... , The findings, published July 29 in ... potential consequences of chronic stress -- such as ...
Breaking Medicine News(10 mins):Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4Health News:Genomic analysis of prostate cancer indicates best course of action after surgery 2Health News:Determine patient preferences by means of conjoint analysis 2Health News:Determine patient preferences by means of conjoint analysis 3Health News:Determine patient preferences by means of conjoint analysis 4Health News:Mortality rates increase due to extreme heat and cold 2Health News:A new brain-based marker of stress susceptibility 2
... 26 Concentric Medical, Inc., the global leader in ... announced that the company,s Merci Retrieval System(TM) has been ... August 2004. The Merci Retrieval System is a ... remove blood clots from patients suffering an ischemic stroke. ...
... Group at Frost & Sullivan is ... Presentation on the European Orphan Diseases Market to ... 2 p.m. GMT.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )Today,s pharmaceutical companies ... market because of the patent expiry of blockbuster ...
... of advanced health screening solutions in local communities, announces the deployment ... make the investment in the new unit in response to increased ... to increased capacity requirements related to the company,s planned geographical expansion ... ...
... Inc. anticipates growth and expansion of telemedicine services to include ... mental health centers. , ... N. ... continues to advance, regulations pertaining to hospital and physician reimbursement ...
... tumor characteristics that may help indicate which breast cancer patients ... to remove the unaffected breast. Published in the March ... of the American Cancer Society, the study could help patients ... diagnosed with breast cancer are known to be at increased ...
... procedure to remove the unaffected breast in breast cancer patients ... patients who have high-risk features as assessed by examining the ... to researchers at The University of Texas M. D. Anderson ... 1, 2009 issue of Cancer , may help physicians ...
Cached Medicine News:Health News:Concentric Medical Reaches Important Stroke Milestone 2Health News:Concentric Medical Reaches Important Stroke Milestone 3Health News:Frost & Sullivan to Host Analyst Briefing on the European Orphan Diseases Market: Niche-Busters - An Attractive Future? 2Health News:HealthYes! Announces Deployment of a New Mobile Health Screening Unit 2Health News:HealthYes! Announces Deployment of a New Mobile Health Screening Unit 3Health News:A Newly Approved CMS Medicare Package Expands Reimbursement Coverage for Telehealth Originating Sites Beginning January 1, 2009 2Health News:Study examines risk factors for cancer in unaffected breast of breast cancer patients 2Health News:Researchers identify risk factors for contralateral breast cancer 2
(Date:7/29/2014)... LONDON , July 29, 2014 ... 2014 Global Frost & Sullivan Best Practices Award ... solution is a cloud-based platform that connects digital ... - such as providers, pharmaceutical companies, prevention and ... electronics. Each year, Frost & ...
(Date:7/29/2014)... , July 29, 2014   Health 2.0 ... a keynote alongside visionary physicians Eric Topol , ... at the Health 2.0 8th Annual Fall Conference ... This year, Health 2.0 is set to host ... of the larger session on Consumer Tech & Wearables: ...
(Date:7/28/2014)... Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) today ... webcast to discuss financial results for the second quarter of ... 2014 at 4:30 p.m. ET. Conference call ... 2014 Time: 4:30 PM ET Listen via Internet: http://ir.pharmacyclics.com/events.cfm ... A webcast replay will be available on the Pharmacyclics website ...
Breaking Medicine Technology:Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 2Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 3Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 4Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2
... Inc. (OTC Bulletin Board: WGBS ), a leading developer ... an overview of the company at the 13th annual BIO CEO ... Hotel, Tuesday, February 15, 2011 at 11:30 a.m. Eastern time.  The ... may be accessed at www.wafergen.com . The BIO ...
... Caliper Life Sciences, Inc. (Nasdaq: CALP ) ... protocols on its Sciclone® NGS Workstation for Illumina,s TruSeq™ ... In addition to the automation protocols for TruSeq kits, ... library preparation kits, as well as for Agilent,s SureSelect™ ...
Cached Medicine Technology:WaferGen to Present at 13th Annual BIO CEO and Investor Conference 2Caliper Life Sciences Announces Availability of Automated TruSeq™ Next Generation Sequencing Protocols 2
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
... BchiVac V-500 with Vacuum Controller V-800 Efficiently ... turns V-500 on and off as needed to maintain ... Model V-500 is a powerful PTFE membrane vacuum pump ... Ideally suited for use with up to two ...
... V-1000 is a new addition to the powerful ... high performance pump can achieve an ultimate vacuum ... 64 L/min. Applications For use ... Distillation applications from lab size up ...
... is a powerful PTFE membrane vacuum pump designed ... Ideally suited for use with up to ... for instruments including vacuum ovens, concentrators, gel dryers, ... PEEK head resistant to chemicals and heat ...
Medicine Products: